Susan Guest has been deprived of sex with her husband. The couple, who have been together for over 40 years, are devastated – ...
New strategy for reducing post-amputation pain ... a greater reduction in opioid use than individuals in the opioid-only treatment, according to the news release. “It’s remarkable how simple ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in ...
Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars in US Strengthens US immunology portfolio and increases access to ...
BACKGROUND: Oral metronidazole has been reported to be effective in some patients with idiopathic lichen planus (LP ... the efficacy of this drug in the treatment of generalized LP.
will be available immediately on the NHS. The treatment, called blinatumomab (also known as Blincyto), works in a completely new way. It helps the body's own immune system recognise and destroy cancer ...
Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.
Hundreds of people in England with aggressive blood cancer are set to benefit from an innovative new treatment that reprogrammes a patient’s own immune cells to fight the disease after it was ...
The findings were published today in a letter to the New England Journal of Medicine ... muscle weakness that leads to death. Currently, treatments for SMA-1 have demonstrated improved survival ...
However, there’s new hope for patients whose previous treatment options might not have worked. In February 2024, the Food and Drug Administration approved the first cellular therapy to treat ...
Doctors say it’s more likely to spread to other parts of the body, if not found and treated early. However, there’s new hope for patients whose previous treatment options might not have worked. In ...